CLINICAL_TRIALS
trial_result
· 2016-08-24
Clinical Trial Update: Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus [Phase 2]
Summary
A Phase 2 clinical trial evaluating Ro 205-2349 for Type 2 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Diabetes | Phase 2 | Status: COMPLETED